Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
25780 | 224 | 17.7 | 38% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
3413 | 1150 | CILOSTAZOL//CLIN PHARMACOKINET PHARMACODYNAM METAB//AZECINES |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | AZECINES | Author keyword | 11 | 100% | 3% | 6 |
2 | LEHRSTUHL PHARMAZEUT MED CHEM | Address | 8 | 37% | 8% | 17 |
3 | LE300 | Author keyword | 6 | 100% | 2% | 4 |
4 | AZECINE | Author keyword | 4 | 67% | 2% | 4 |
5 | LE 300 | Author keyword | 3 | 100% | 1% | 3 |
6 | METHYL EPSILON HYDROXYCARBOXYLATES | Author keyword | 3 | 100% | 1% | 3 |
7 | EPSILON LACTONES | Author keyword | 2 | 67% | 1% | 2 |
8 | CARBOXYLIC ACIDS EPSILON HYDROXY | Author keyword | 1 | 100% | 1% | 2 |
9 | DOPAMINE RECEPTOR LIGAND | Author keyword | 1 | 40% | 1% | 2 |
10 | 5 HT2A LIGAND | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | AZECINES | 11 | 100% | 3% | 6 | Search AZECINES | Search AZECINES |
2 | LE300 | 6 | 100% | 2% | 4 | Search LE300 | Search LE300 |
3 | AZECINE | 4 | 67% | 2% | 4 | Search AZECINE | Search AZECINE |
4 | LE 300 | 3 | 100% | 1% | 3 | Search LE+300 | Search LE+300 |
5 | METHYL EPSILON HYDROXYCARBOXYLATES | 3 | 100% | 1% | 3 | Search METHYL+EPSILON+HYDROXYCARBOXYLATES | Search METHYL+EPSILON+HYDROXYCARBOXYLATES |
6 | EPSILON LACTONES | 2 | 67% | 1% | 2 | Search EPSILON+LACTONES | Search EPSILON+LACTONES |
7 | CARBOXYLIC ACIDS EPSILON HYDROXY | 1 | 100% | 1% | 2 | Search CARBOXYLIC+ACIDS++EPSILON+HYDROXY | Search CARBOXYLIC+ACIDS++EPSILON+HYDROXY |
8 | DOPAMINE RECEPTOR LIGAND | 1 | 40% | 1% | 2 | Search DOPAMINE+RECEPTOR+LIGAND | Search DOPAMINE+RECEPTOR+LIGAND |
9 | 5 HT2A LIGAND | 1 | 50% | 0% | 1 | Search 5+HT2A+LIGAND | Search 5+HT2A+LIGAND |
10 | COCAINE ADDICTION TREATMENT | 1 | 50% | 0% | 1 | Search COCAINE+ADDICTION+TREATMENT | Search COCAINE+ADDICTION+TREATMENT |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DOPAMINE SEROTONIN RECEPTOR LIGANDS | 6 | 71% | 2% | 5 |
2 | D 1 D 5 ANTAGONISTS | 1 | 100% | 1% | 2 |
3 | IMIDOLACTONES | 1 | 100% | 1% | 2 |
4 | ISOQUINO1 2 ALPHA2BENZAZEPINES | 1 | 100% | 1% | 2 |
5 | MICROPLATE READER | 1 | 20% | 2% | 4 |
6 | DINAPSOLINE ANALOGS | 1 | 50% | 0% | 1 |
7 | BAUERINE C | 0 | 33% | 0% | 1 |
8 | CATALYZED COCYCLOTRIMERIZATION | 0 | 33% | 0% | 1 |
9 | D 1 D 5 RECEPTORS | 0 | 33% | 0% | 1 |
10 | DOPAMINE D 1 D 5 RECEPTORS | 0 | 33% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Dopamine D-5 receptors: A challenge to medicinal chemists | 2008 | 7 | 59 | 15% |
The Chemistry of Pyrido[1,2-a] azepines and Their Hydro Derivatives | 2011 | 4 | 163 | 12% |
DIELS-ALDER ADDUCTS OF FURAN-DERIVATIVES IN SYNTHESIS OF CARBOCYCLIC AND HETEROCYCLIC-SYSTEMS | 1985 | 2 | 14 | 36% |
Chemistry and Heterocyclization of Carbohydrazides | 2010 | 11 | 57 | 2% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LEHRSTUHL PHARMAZEUT MED CHEM | 8 | 37% | 7.6% | 17 |
2 | ABT MED CHEM | 1 | 50% | 0.4% | 1 |
3 | GVC C | 1 | 50% | 0.4% | 1 |
4 | PHARM PHARMAZEUT MED CHEM | 1 | 50% | 0.4% | 1 |
5 | QUIM ORGAN UNIDAD ASOC | 1 | 50% | 0.4% | 1 |
6 | EX CHEM SCI | 0 | 100% | 0.4% | 1 |
7 | LEHRSTUHL PHARMACEUT MED CHEM | 0 | 100% | 0.4% | 1 |
8 | LEHTUHL PHARMAZEUT MED CHEM | 0 | 100% | 0.4% | 1 |
9 | TEMPORARILY GENOM FONCT | 0 | 100% | 0.4% | 1 |
10 | TOXICOLNEUROTOXICOL GRP | 0 | 100% | 0.4% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000102536 | FINE ORGAN SYNTH//SINTESIS ORGAN FINA//GRP PROD NAT |
2 | 0.0000099390 | ACID INDUCED INDOLE CYCLIZATION//22810 TAMAGAWA SETAGAYA KU//DECARBOXYLATIVE CYCLIZATION |
3 | 0.0000091812 | DIMEBON//DIMEBOLIN//LATREPIRDINE |
4 | 0.0000085632 | MOUSE LYMPHOID NEOPLASMA P 388//MOUSE MAMMARY CARCINOMA FM 3A//HUMAN HISTIOCYTIC LYMPHOMA U 937 |
5 | 0.0000073876 | CONJUGATED AZOMETHINE YLIDE//AZEPINES//CINCIAS QUIM |
6 | 0.0000069340 | FASCAPLYSIN//PICTET SPENGLER REACTION//BETA CARBOLINE |
7 | 0.0000058583 | FUSED 1 4 DIHYDROPYRIDINES//BIS MANNICH BASES//CYCLIC ENEHYDRAZINO KETONES |
8 | 0.0000055301 | ZJ0273//PYRIBENZOXIM//KIH 6127 |
9 | 0.0000052538 | NEFOPAM//ORPHENADRINE//ANALGESICS NON OPIOID NEFOPAM |
10 | 0.0000051724 | TANDEM TRANSFORMATION//TANDEM CLEAVAGE//ACTIVATED ALKYNES |